Oral administration demonstrates activity in gastrointestinal conditions despite lower systemic bioavailability, as direct mucosal exposure may contribute to therapeutic effects
[See USP Controlled Room Temperature.] Distributed by Hospira, Inc., Lake Forest, IL 60045 USA LAB-0977-2.0 Revised: 08/2019
That said, a PCAC vote is advisory, not binding, meaning real-world access for patients hasn't changed
60mg: 1.5mL = 8mg/0.2mL
BPC-157 + TB-500, for the cartilage indication Due to the emerging chondroprotective profile of AOD-9604 (Vukmirovic-Popovic 2010), the research literature features the combination with BPC-157 and TB-500 for indications: Osteoarthritis (intra-articular formulation) Tendinopathy Chondral defects in animal models MOTS-c, metabolic support MOTS-c improves mitochondrial efficiency, released fatty acids from AOD-9604-induced lipolysis can then be more efficiently oxidized
The peptides discussed are intended for laboratory research use only and are not approved for human use
